Gross P A, Kim J K, Anderson R J
Circ Res. 1983 Dec;53(6):794-804. doi: 10.1161/01.res.53.6.794.
The mechanism(s) of renal escape from the hydro-osmotic effect of vasopressin is unknown. We therefore studied escape in conscious, unrestrained rats receiving continuous intravascular infusions of 1-deamino-8-arginine-vasopressin (desmopressin) and hypotonic fluid over 5 days. Escape from desmopressin started 8 hours after exposure and was characterized by a progressive increase in urine flow and decreases in urine osmolality and free water reabsorption. When positive water balance was prevented by matching the rate of infusion of hypotonic fluid to urine flow while maintaining the dose of desmopressin constant, escape did not occur. This suggested that water retention, rather than chronic exposure to desmopressin, mediated the escape. To elucidate the mechanism whereby water retention induces escape from desmopressin, urinary prostaglandin E2 excretion was measured and found to be increased concomitant with the onset of escape. Prevention of this increase in urinary prostaglandin E2 excretion with indomethacin resulted in additional water retention and a delay in the onset of escape. During the maintenance of escape, after significant water retention occurred, increases in mean arterial pressure, renal blood flow, and glomerular filtration rate were observed. Renal interstitial solute concentration remained constant through escape. Basal and vasopressin-stimulated collecting tubular and thick ascending limb adenylate cyclase did not differ when control and escape animals were compared. These results suggest that enhanced renal synthesis of prostaglandin E2 facilitates the early phase of escape; later, water retention results in plasma volume expansion with increases in cardiac index, arterial pressure, renal blood flow, and glomerular filtration rate. These systemic and renal hemodynamic alterations may be important in maintaining escape from desmopressin.
肾脏对血管加压素水渗透作用产生逃逸的机制尚不清楚。因此,我们对清醒、不受限制的大鼠进行了研究,这些大鼠连续5天接受血管内输注1-去氨基-8-精氨酸血管加压素(去氨加压素)和低渗液。去氨加压素逃逸在暴露8小时后开始,其特征是尿流量逐渐增加,尿渗透压和自由水重吸收减少。当通过使低渗液输注速率与尿流量相匹配来防止正水平衡,同时保持去氨加压素剂量恒定时,逃逸未发生。这表明水潴留而非长期暴露于去氨加压素介导了逃逸。为阐明水潴留诱导去氨加压素逃逸的机制,我们测量了尿前列腺素E2排泄量,发现其随着逃逸开始而增加。用吲哚美辛阻止尿前列腺素E2排泄量的这种增加会导致额外的水潴留并延迟逃逸的开始。在逃逸维持期间,在发生显著水潴留后,观察到平均动脉压、肾血流量和肾小球滤过率增加。在整个逃逸过程中肾间质溶质浓度保持恒定。比较对照动物和逃逸动物时,基础状态和血管加压素刺激的集合管及髓袢升支粗段腺苷酸环化酶无差异。这些结果表明,肾内前列腺素E2合成增强促进了逃逸的早期阶段;随后,水潴留导致血浆容量扩张,伴有心脏指数、动脉压、肾血流量和肾小球滤过率增加。这些全身和肾脏的血流动力学改变可能对维持从去氨加压素的逃逸很重要。